Alternative DNA structure formation in the mutagenic human c-MYC promoter

Nucleic Acids Res. 2017 May 5;45(8):4929-4943. doi: 10.1093/nar/gkx100.

Abstract

Mutation 'hotspot' regions in the genome are susceptible to genetic instability, implicating them in diseases. These hotspots are not random and often co-localize with DNA sequences potentially capable of adopting alternative DNA structures (non-B DNA, e.g. H-DNA and G4-DNA), which have been identified as endogenous sources of genomic instability. There are regions that contain overlapping sequences that may form more than one non-B DNA structure. The extent to which one structure impacts the formation/stability of another, within the sequence, is not fully understood. To address this issue, we investigated the folding preferences of oligonucleotides from a chromosomal breakpoint hotspot in the human c-MYC oncogene containing both potential G4-forming and H-DNA-forming elements. We characterized the structures formed in the presence of G4-DNA-stabilizing K+ ions or H-DNA-stabilizing Mg2+ ions using multiple techniques. We found that under conditions favorable for H-DNA formation, a stable intramolecular triplex DNA structure predominated; whereas, under K+-rich, G4-DNA-forming conditions, a plurality of unfolded and folded species were present. Thus, within a limited region containing sequences with the potential to adopt multiple structures, only one structure predominates under a given condition. The predominance of H-DNA implicates this structure in the instability associated with the human c-MYC oncogene.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Breakage / drug effects
  • DNA / chemistry*
  • DNA / drug effects
  • DNA Replication / drug effects
  • G-Quadruplexes / drug effects
  • Genomic Instability / drug effects
  • Humans
  • Mutagens / toxicity
  • Mutation / drug effects
  • Nucleic Acid Conformation / drug effects*
  • Oligonucleotides / chemistry*
  • Oligonucleotides / genetics
  • Promoter Regions, Genetic / drug effects
  • Proto-Oncogene Proteins c-myc / chemistry*
  • Proto-Oncogene Proteins c-myc / genetics
  • Transcription, Genetic / drug effects

Substances

  • MYC protein, human
  • Mutagens
  • Oligonucleotides
  • Proto-Oncogene Proteins c-myc
  • triplex DNA
  • DNA